All In Biotech

Drug Trial Radar · NCT06263959

A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B

Last checked: Nov 20, 2026Latest source record: Mar 5, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

45

Planned (sponsor's estimate)

Start

Dec 26, 2023

Primary completion

Apr 1, 2025

Study completion May 1, 2025

Sponsor

Sponsor type
Industry
First posted
Feb 16, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 35 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A randomized, double-blind, placebo-controlled Phase IIa clinical study to evaluate the safety and efficacy of GST-HG131 tablets in patients with chronic hepatitis B

Conditions

  • Chronic Hepatitis B

Interventions

  • GST-HG131Drug

    GST-HG131 will be administered.

  • Placebo to match GST-HG131Drug

    Placebo to match GST-HG131 will be administered.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from Baseline in HBsAg levelsTime frame: Baseline and up to 56 days(Cohort1 and 2) or 16 weeks(Cohort3)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The Fifth Medical Center of Chinese PLA General Hospital

    Beijing, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.